Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Cellular Longevity, Inc.

Cellular Longevity, Inc.

Stage unknownSan Francisco, CAOther Technology
Facts
Year of incorporation
2019sec.gov
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
1
Financing history
2 rounds
  1. Oct 11, 2024
    Form D equity offering · $22.2M (form d sold) · 12 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Cellular Longevity, Inc. filed Form D: $22,174,971 sold of $32,499,972, Other Technology”
  2. Mar 5, 2024
    Form D equity offering · $76.3M (form d sold) · 38 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Cellular Longevity, Inc. filed Form D: $76,280,239 sold of $76,280,239, Other Technology”
Investors on record
1 edges
People
1 officers, 4 directors
Timeline
2
  1. Oct 28, 2024
    Cellular Longevity, Inc. filed Form D: $22,174,971 sold of $32,499,972, Other Technology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Mar 29, 2024
    Cellular Longevity, Inc. filed Form D: $76,280,239 sold of $76,280,239, Other Technology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
29 observations
Every observation on this company